Skip to main content

Table 1 Demographic features of the study population

From: Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

  

n

Total group (N = 151)

 

Preclinical AD (n = 28)

Subthreshold psychiatry (n = 58)

Undetermined (n = 65)

p

Demographics

Age

151

64 ± 8

 

69 ± 7b

62 ± 8a

64 ± 8a

0.002

Gender, female

151

67 (44)

 

11 (39)

27 (47)

29 (45)

NS

Education (years)

148

12 ± 3

 

13 ± 3

12 ± 3

12 ± 2

NS

Family history dementia

140

76 (54)

 

18 (75)b

20 (36)a

38 (62)b

0.002

APOE e4 carrier

144

55 (38)

 

17 (65)b

17 (30)a

21 (34)a

0.007

   

n above cutoff value

    

Subjective cognitive decline

SCF (1-year change) self-report

150

−1.65 ± 2.98

104 (69)

−2.0 ± 2.3

−2.4 ± 3.2

−0.8 ± 2.9b

0.004

CCI (5-year change) self-reportc

148

21.8 ± 14.3

89 (60)

21.4 ± 13.2b

27.8 ± 15.2a

16.7 ± 11.8b

0.000

CCI (5-year change) informantc

127

19.4 ± 17.1

62 (49)

19.8 ± 13.9b

26.4 ± 19.1a

13.8 ± 14.8b

0.000

Mental health questionnaires

Quality of Life

149

76 ± 15

 

79 ± 12

71 ± 16

80 ± 15b

0.012

Depressive symptomsc

150

8.3 ± 6.4

17 (11)

7.0 ± 4.6

12.1 ± 7.3

5.5 ± 4.1

0.000

Anxietyc

150

4.0 ± 2.9

13 (13)

4.1 ± 2.6

5.6 ± 3.1

2.4 ± 1.9

0.000

Distressc

150

6.7 ± 5.9

34 (22)

4.6 ± 4.6

11.1 ± 6.3

3.6 ± 2.9

0.000

Somatizationc

151

6.3 ± 5.3

31 (21)

4.6 ± 3.7

10.3 ± 5.7

3.5 ± 2.8

0.000

Neuroticismc

145

6.6 ± 5.5

 

5.2 ± 3.8

10.1 ± 6.4

4.0 ± 2.8

0.000

Low masteryc

140

10.5 ± 3.9

 

10.0 ± 3.0

12.8 ± 4.0

8.5 ± 2.7

0.000

Cognition

MMSE

151

28.6 ± 1.2

 

28.4 ± 1.3

28.5 ± 1.2

28.9 ± 1.2

0.031

 Memory domain

RAVLT immediate recall

149

44.3 ± 9.0

 

43.4 ± 8.7

44.0 ± 9.0

44.6 ± 9.2

NS

RAVLT delayed recall

149

9.0 ± 2.9

 

8.5 ± 2.9

9.1 ± 3.0

9.2 ± 2.9

NS

RAVLT cued recall

149

28.7 ± 1.6

 

28.7 ± 1.5

28.5 ± 2.3

28.8 ± 1.4

NS

 Attention

TMT Ac

148

34.4 ± 12.8

 

33.4 ± 12.2b

37.5 ± 14.9a

32.1 ± 10.5b

0.014

 Executive functioning

TMT Bc

147

82.1 ± 33.2

 

79.5 ± 28.9

89.8 ± 41.0

76.2 ± 25.8b

0.058

 Language

Animal fluency

147

23.2 ± 5.2

 

22.8 ± 4.9

23.1 ± 5.1

23.5 ± 5.6

NS

MRI

Normalized brain volume (ml)

116

1399 ± 79

 

1366 ± 75

1407 ± 81

1406 ± 79

NS

Bilateral hippocampal volume (ml)

116

9.9 ± 1.3

 

10.0 ± 1.4

9.9 ± 1.3

9.8 ± 1.1

NS

White-matter hyperintensities (present)

116

10 (9)

 

2 (9)

2 (4)

6 (13)

NS

Lacunes (> 0)

115

3 (3)

 

1 (4)

2 (5)

0 (0)

NS

Microbleeds present (> 0)

112

19 (17)

 

7 (30)

4 (10)

8 (17)

NS

  1. Unadjusted results presented as mean ± standard deviation or n (%). Differences between groups assessed using age, gender, and education-adjusted analysis of variance or chi-squared tests
  2. AD Alzheimer’s disease, APOE apolipoprotein E genotype, CCI cognitive change index, MMSE Mini-Mental State Examination, MRI magnetic resonance imaging, NS not significant, RAVLT Rey Auditory Verbal Learning Test, SCF subjective cognitive functioning, TMT Trail Making Test
  3. ap < 0.05 difference with preclinical AD
  4. bp < 0.05 difference with subthreshold psychiatry
  5. cHigher scores reflect worse performance or more symptoms